- en: <!--yml
  id: totrans-split-0
  prefs: []
  type: TYPE_NORMAL
- en: 'category: 未分类'
  id: totrans-split-1
  prefs: []
  type: TYPE_NORMAL
- en: 'date: 2024-05-29 12:38:58'
  id: totrans-split-2
  prefs: []
  type: TYPE_NORMAL
- en: -->
  id: totrans-split-3
  prefs: []
  type: TYPE_NORMAL
- en: CBD products don’t ease pain and are potentially harmful – new study finds
  id: totrans-split-4
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
- en: 来源：[https://www.bath.ac.uk/announcements/cbd-products-dont-ease-pain-and-are-potentially-harmful-new-study-finds/](https://www.bath.ac.uk/announcements/cbd-products-dont-ease-pain-and-are-potentially-harmful-new-study-finds/)
  id: totrans-split-5
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
- en: There is no evidence that CBD products reduce chronic pain, and taking them
    is a waste of money and potentially harmful to health, according to new research
    led by the University of Bath.
  id: totrans-split-6
  prefs: []
  type: TYPE_NORMAL
- en: CBD (short for cannabidiol) is one of many chemicals found naturally in the
    cannabis plant. It’s a popular alternative treatment for pain and is readily available
    in shops and online in the form of oils, tinctures, vapes, topical creams, edibles
    (such as gummy bears) and soft drinks.
  id: totrans-split-7
  prefs: []
  type: TYPE_NORMAL
- en: However, consumers would do well to steer clear of these products, according
    to the [new study](https://doi.org/10.1016/j.jpain.2023.10.009).
  id: totrans-split-8
  prefs: []
  type: TYPE_NORMAL
- en: “CBD presents consumers with a big problem,” said [Professor Chris Eccleston](https://researchportal.bath.ac.uk/en/persons/christopher-eccleston),
    who led the research from the [Centre for Pain Research](https://www.bath.ac.uk/research-centres/centre-for-pain-research-cpr/)
    at Bath. “It’s touted as a cure for all pain but there’s a complete lack of quality
    evidence that it has any positive effects.”
  id: totrans-split-9
  prefs: []
  type: TYPE_NORMAL
- en: 'He added: “It’s almost as if chronic pain patients don’t matter, and that we’re
    happy for people to trade on hope and despair.”'
  id: totrans-split-10
  prefs: []
  type: TYPE_NORMAL
- en: For their study, published this week in *The Journal of Pain*, the team – which
    included researchers from the Universities of Bath, Oxford and Alberta in Canada
    – examined research relevant to using CBD to treat pain and published in scientific
    journals up to late 2023\.
  id: totrans-split-11
  prefs: []
  type: TYPE_NORMAL
- en: 'They found:'
  id: totrans-split-12
  prefs: []
  type: TYPE_NORMAL
- en: CBD products sold direct to consumers contain varying amounts of CBD, from none
    to much more than advertised.
  id: totrans-split-13
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: CBD products sold direct to consumers may contain chemicals other than CBD,
    some of which may be harmful and some illegal in some jurisdictions. Such chemicals
    include THC (tetrahydrocannabinol), the main psychoactive component of the cannabis
    plant.
  id: totrans-split-14
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: Of the 16 randomised controlled trials that have explored the link between pain
    and pharmaceutical-grade CBD, 15 have shown no positive results, with CBD being
    no better than placebo at relieving pain.
  id: totrans-split-15
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: A meta-analysis (which combines data from multiple studies and plays a fundamental
    role in evidence-based healthcare) links CBD to increased rates of serious adverse
    events, including liver toxicity.
  id: totrans-split-16
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: Medical vs non-medical CBD
  id: totrans-split-17
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
- en: In the UK, medical cannabis is the only CBD product that is subject to regulatory
    approval. It's occasionally prescribed for people with severe forms of epilepsy,
    adults with chemotherapy-related nausea and people with multiple sclerosis.
  id: totrans-split-18
  prefs: []
  type: TYPE_NORMAL
- en: Non-medical CBD is freely available in the UK (as well as in the US and many
    European countries) so long as it contains negligible quantities of THC or none
    at all. However, CBD products sold on the retail market are not covered by trade
    standards, meaning there is no requirement for them to be consistent in content
    or quality.
  id: totrans-split-19
  prefs: []
  type: TYPE_NORMAL
  zh: 在英国（以及美国和许多欧洲国家），非药用CBD是自由获取的，只要它含有可忽略的THC量或者完全不含。然而，零售市场上销售的CBD产品不受贸易标准保护，这意味着它们在内容或质量上没有一致性要求。
- en: Most CBD products bought online – including popular CBD oils – are known to
    contain very small amounts of CBD. Moreover, any given product may be [illegal
    to possess or supply](https://www.nhs.uk/conditions/medical-cannabis/#:%7E:text=Epidyolex%20for%20children%20and%20adults,cannabis%20that%20makes%20you%20high.),
    as there’s a good chance it will contain forbidden quantities of THC.
  id: totrans-split-20
  prefs: []
  type: TYPE_NORMAL
  zh: 大多数在线购买的CBD产品，包括热门的CBD油，据称含有极少量的CBD。此外，由于其中很可能含有禁用量的THC，任何特定产品都可能是[非法持有或供应的](https://www.nhs.uk/conditions/medical-cannabis/#:%7E:text=Epidyolex%20for%20children%20and%20adults,cannabis%20that%20makes%20you%20high.)。
- en: Chronic pain
  id: totrans-split-21
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 慢性疼痛
- en: An estimated [20% of the adult population](https://academic.oup.com/bja/article/111/1/13/330341)
    lives with chronic pain, and sufferers are often desperate for help to alleviate
    their symptoms. It’s no surprise then that many people reach for CBD products,
    despite their high price tag and the lack of evidence of their effectiveness or
    safety.
  id: totrans-split-22
  prefs: []
  type: TYPE_NORMAL
  zh: 大约有[成年人口的20%](https://academic.oup.com/bja/article/111/1/13/330341)生活在慢性疼痛中，病患通常渴望找到帮助来缓解他们的症状。因此，尽管CBD产品价格高昂且缺乏其有效性或安全性的证据，许多人仍然会选择使用。
- en: 'Dr Andrew Moore, study co-author and former senior pain researcher in the Nuffield
    Division of Anaesthetics at the University of Oxford, said: “For too many people
    with chronic pain, there’s no medicine that manages their pain. Chronic pain can
    be awful, so people are very motivated to find pain relief by any means. This
    makes them vulnerable to the wild promises made about CBD.”'
  id: totrans-split-23
  prefs: []
  type: TYPE_NORMAL
  zh: 安德鲁·摩尔博士，牛津大学努菲尔德麻醉学部门的前资深疼痛研究员和研究共同作者说：“对于许多患有慢性疼痛的人来说，没有药物可以管理他们的疼痛。慢性疼痛可以让人难受，因此人们非常有动力通过任何方式寻找疼痛缓解。这使他们容易受到有关CBD的夸大承诺的影响。”
- en: He added that healthcare regulators appear reluctant to act against the spurious
    claims made by some manufacturers of CBD products, possibly because they don’t
    want to interfere in a booming market (the global CBD product market was estimated
    at [US$3 billion in 2021](https://www.custommarketinsights.com/report/cbd-product-market/#:%7E:text=According%20to%20Custom%20Market%20Insights%20%28CMI%29%2C%20the%20Global,CAGR%20of%20roughly%2011%25%20between%202022%20and%202030.)
    or £2.4 billion and is anticipated to reach [US$60 billion by 2030](https://globalcannabistimes.com/cannabinoids-market-to-triple-to-60-billion-by-2030-cbd-segment-leads-u-s-sales/)
    or £48 billion) especially when the product on sale is widely regarded as harmless.
  id: totrans-split-24
  prefs: []
  type: TYPE_NORMAL
  zh: 他补充说，卫生保健监管机构似乎不愿意对某些CBD产品制造商所作出的虚假声明采取行动，可能是因为他们不希望干涉一个蓬勃发展的市场（全球CBD产品市场在2021年估计为[30亿美元](https://www.custommarketinsights.com/report/cbd-product-market/#:%7E:text=According%20to%20Custom%20Market%20Insights%20%28CMI%29%2C%20the%20Global,CAGR%20of%20roughly%2011%25%20between%202022%20and%202030.)或24亿英镑，并预计到2030年将达到[600亿美元](https://globalcannabistimes.com/cannabinoids-market-to-triple-to-60-billion-by-2030-cbd-segment-leads-u-s-sales/)或480亿英镑）尤其是在产品被广泛认为无害的情况下。
- en: “What this means is that there are no consumer protections,” said Dr Moore.
    “And without a countervailing body to keep the CBD sellers in check, it’s unlikely
    that the false promises being made about the analgesic effects of CBD will slow
    down in the years ahead.”
  id: totrans-split-25
  prefs: []
  type: TYPE_NORMAL
  zh: “这意味着消费者没有任何保护措施，” Moore博士说道。“没有反制措施来监督CBD销售者，CBD的止痛效果的虚假承诺在未来几年内不太可能减少。”
- en: The study’s authors are calling for chronic pain to be taken more seriously,
    with consumer protection becoming a priority.
  id: totrans-split-26
  prefs: []
  type: TYPE_NORMAL
  zh: 研究的作者呼吁更加重视慢性疼痛问题，消费者保护应成为首要任务。
- en: “Untreated chronic pain is known to seriously damage quality of life, and many
    people live with pain every day and for the rest of their lives,” said Professor
    Eccleston. “Pain deserves investment in serious science to find serious solutions.”
  id: totrans-split-27
  prefs: []
  type: TYPE_NORMAL
  zh: 埃克尔斯顿教授说：“未经治疗的慢性疼痛已知严重损害生活质量，许多人每天和终身都生活在疼痛之中。疼痛值得投资严肃的科学以找到有效的解决方案。”
